These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14766420)

  • 1. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Rezania K; Gundogdu B; Soliven B
    Front Biosci; 2004 Jan; 9():939-45. PubMed ID: 14766420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune mechanisms in chronic inflammatory demyelinating neuropathy.
    Kieseier BC; Dalakas MC; Hartung HP
    Neurology; 2002 Dec; 59(12 Suppl 6):S7-12. PubMed ID: 12499465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Inflammatory Demyelinating Polyneuropathy.
    Kuwabara S; Misawa S
    Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Mahdi-Rogers M; Hadden RD; Peakman M; Gregson N; Nemni R; Hughes RA
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):333-8. PubMed ID: 19015227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.
    Mathey EK; Park SB; Hughes RA; Pollard JD; Armati PJ; Barnett MH; Taylor BV; Dyck PJ; Kiernan MC; Lin CS
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):973-85. PubMed ID: 25677463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
    Aranami T; Yamamura T
    Nihon Rinsho; 2013 May; 71(5):850-4. PubMed ID: 23777093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.
    Illa I
    J Peripher Nerv Syst; 2017 Dec; 22(4):418-424. PubMed ID: 29065233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
    Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.
    Lewis RA
    Semin Neurol; 2005 Jun; 25(2):217-28. PubMed ID: 15937737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Allen D; Makowska A; Gregson NA
    J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of autoimmune neuropathy.
    Soliven B
    ILAR J; 2014; 54(3):282-90. PubMed ID: 24615441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.
    Hagen KM; Ousman SS
    J Neuroinflammation; 2021 Mar; 18(1):78. PubMed ID: 33752693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
    J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy.
    Comi C; Gaviani P; Leone M; Ferretti M; Castelli L; Mesturini R; Ubezio G; Chiocchetti A; Osio M; Muscia F; Bogliun G; Corso G; Gavazzi A; Mariani C; Cantello R; Monaco F; Dianzani U
    J Peripher Nerv Syst; 2006 Mar; 11(1):53-60. PubMed ID: 16519782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms in spontaneously occurring CIDP in NOD mice.
    Soliven B
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():56-9. PubMed ID: 21696501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in experimental models of antibody-mediated neuropathies.
    Willison HJ
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():60-2. PubMed ID: 21696502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.